bf/NASDAQ:SMMT_icon.jpeg

NASDAQ:SMMT

Summit Therapeutics Inc.

  • Stock

USD

Last Close

4.96

09/05 20:00

Market Cap

2.72B

Beta: −1.02

Volume Today

2.08M

Avg: 2.06M

PE Ratio

−1.63

PFCF: −51.96

Jan '14
Jan '15
Jan '16
Jan '17
Jan '18
Jan '19
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.21
-
0.08
62.57%
0.06
-
0.47
668.47%
0.72
52.78%
1.76
144.56%
0.01
99.52%
0.02
90.17%
0.00
93.35%
cash conversion cycle
-47.25K
-
-170.30K
260.43%
cash per share
0.69
-
0.43
38.20%
0.39
8.34%
0.57
45.05%
0.43
23.70%
0.41
5.48%
0.96
-
0.55
42.94%
1.80
230.82%
0.30
83.33%
company equity multiplier
1.39
-
1.30
6.93%
1.19
8.44%
-10.76
1,006.86%
5.46
150.78%
1.40
74.29%
0.57
59.10%
1.29
124.54%
1.36
5.52%
5.24
285.22%
2.61
50.19%
days of inventory outstanding
434.62
-
days of payables outstanding
47.25K
-
170.30K
260.43%
474.86
-
days of sales outstanding
147.68
-
191.13
29.42%
600.36
-
4.32K
-
3.46K
19.92%
3.17K
8.46%
dividend yield
ebit per revenue
-4.88
-
-8.44
73.06%
-10.79
-
-0.51
95.30%
0.22
143.27%
0.35
60.55%
-61.85
17,653.39%
-47.64
22.97%
-102.36
114.84%
ebt per ebit
1.00
-
1.00
0.27%
1.00
0.25%
1.03
3.59%
0.84
18.33%
0.53
36.92%
0.33
38.17%
0.99
201.87%
1.03
3.35%
1.09
6.30%
6.86
528.01%
effective tax rate
0.09
-
0.10
13.08%
0.15
48.16%
0.17
11.12%
0.35
104.75%
-0.50
243.65%
0.00
-
0.03
588.28%
0.06
101.61%
0.00
97.25%
enterprise value multiple
-2.40
-
-12.93
438.70%
-11.81
8.68%
-15.29
29.46%
-44.82
193.09%
3.74
108.34%
-1.84
149.17%
-5.07
175.61%
-3.31
34.67%
-16.31
392.77%
-18.84
15.49%
fixed asset turnover
31.98
-
27.37
14.41%
19.86
-
31.42
58.19%
69.82
122.23%
27.93
60.00%
0.67
97.59%
0.52
22.78%
0.14
73.30%
free cash flow per share
-2.02
-
-0.43
78.62%
-0.42
3.84%
0.24
158.89%
-0.33
234.05%
-0.41
25.56%
-0.70
-
-0.55
20.72%
-0.22
60.55%
-0.12
43.16%
gross profit margin
1
-
1
0%
1
-
1.00
0.27%
1.00
0.23%
1
0.04%
1
0%
1
0%
1
0%
interest coverage
-6.99
-
1.29K
18,549.53%
81.85
93.66%
-28.83
135.22%
-11.08
61.58%
22.26
300.99%
-208.60
-
-306.71
47.03%
-16.38
94.66%
-5.45
66.72%
inventory turnover
0.84
-
long term debt to capitalization
1.37
-
7.15
421.47%
0.13
98.18%
0.00
-
0.02
2,010.14%
0.80
3,905.11%
0.57
28.39%
net income per ebt
0.91
-
0.90
1.30%
0.85
5.50%
0.83
1.99%
0.65
21.25%
1.50
128.54%
1
33.16%
1.00
0.40%
0.97
2.38%
0.94
2.90%
1.00
5.75%
net profit margin
-4.43
-
-7.55
70.35%
-9.28
-
-0.28
96.98%
0.17
162.38%
0.12
33.65%
-61.28
52,875.04%
-47.62
22.28%
-105.61
121.77%
operating cash flow per share
-2.01
-
-0.43
78.51%
-0.41
3.91%
0.25
159.55%
-0.32
228.87%
-0.41
29.05%
-0.69
-
-0.55
20.36%
-0.22
60.97%
-0.12
42.40%
operating cycle
operating profit margin
-4.88
-
-8.44
73.06%
-10.79
-
-0.51
95.30%
0.22
143.27%
0.35
60.55%
-61.85
17,653.39%
-47.64
22.97%
-102.36
114.84%
payables turnover
0.01
-
0.00
72.26%
0.77
-
pretax profit margin
-4.87
-
-8.41
72.60%
-11.16
-
-0.43
96.16%
0.12
127.29%
0.12
0.74%
-61.52
53,088.35%
-48.98
20.39%
-111.86
128.38%
price fair value
3.80
-
11.87
212.63%
12.58
6.02%
-116.55
1,026.34%
45.08
138.68%
1.56
96.54%
4.11
-
4.25
3.44%
6.49
52.50%
20.82
220.87%
receivables turnover
2.47
-
1.91
22.73%
0.61
-
0.08
-
0.11
24.88%
0.12
9.25%
return on assets
-0.92
-
-0.59
36.24%
-0.68
16.32%
-0.57
16.56%
-0.13
76.76%
0.13
195.30%
0.20
62.26%
-0.51
351.60%
-0.76
47.79%
-0.11
85.26%
-3.03
2,605.54%
return on capital employed
-1.41
-
-0.81
42.28%
-0.92
13.44%
-0.93
0.93%
-0.37
60.46%
0.20
154.67%
0.58
186.57%
-0.64
211.63%
-0.98
52.53%
-0.12
88.26%
-0.49
326.46%
return on equity
-1.28
-
-0.76
40.66%
-0.81
6.50%
6.12
856.65%
-0.72
111.80%
0.18
124.50%
0.12
33.64%
-0.66
664.93%
-1.03
55.96%
-0.59
43.22%
-7.91
1,247.74%
total debt to capitalization
-0.34
-
1.26
-
0.11
91.01%
0.13
14.92%
-0.02
118.61%
0.01
124.05%
0.03
455.54%
0.80
2,386.58%
0.58
28.18%

All numbers in USD (except ratios and percentages)